QCM
CLPT icon

Quantinno Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Quantinno Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.44M Buy
80,757
+28,810
+55% +$360K ﹤0.01% 2269
2026
Q1 		$473K Buy
51,947
+39,195
+307% +$495K ﹤0.01% 2750
2025
Q4 		$174K Buy
+12,752
New +$236K ﹤0.01% 3077

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Quantinno Capital Management's CLPT Position: Q2 2026 in Review

Quantinno Capital Management increased its ClearPoint Neuro (CLPT) stake by 55% in Q2 2026, buying an estimated $360K and bringing the position to 80,757 shares worth $1.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2269.

Quantinno Capital Management first reported a position in CLPT in Q4 2025 and has held it in 3 quarters since. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Quantinno Capital Management held 80,757 shares of ClearPoint Neuro worth $1.44M as of Q2 2026.
  • Quantinno Capital Management bought 28,810 ClearPoint Neuro shares in Q2 2026, an estimated $360K.
  • ClearPoint Neuro made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2269 holding.
  • Quantinno Capital Management first reported a position in ClearPoint Neuro in Q4 2025 and has held it in 3 quarters since.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.